Global Glucose Monitoring Device Market Insights, Forecast to 2025
Table of Content
1 Study Coverage
- 1.1 Glucose Monitoring Device Product Introduction
- 1.2 Key Market Segments in This Study
- 1.3 Key Manufacturers Covered: Ranking of Global Top Glucose Monitoring Device Manufacturers by Revenue in 2019
- 1.4 Market by Type
- 1.4.1 Global Glucose Monitoring Device Market Size Growth Rate by Type
- 1.4.2 Diabetes monitoring devices
- 1.4.3 Insulin delivery devices
- 1.5 Market by Application
- 1.5.1 Global Glucose Monitoring Device Market Size Growth Rate by Application
- 1.5.2 Hospitals
- 1.5.3 Personal use
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Glucose Monitoring Device Market Size, Estimates and Forecasts
- 2.1.1 Global Glucose Monitoring Device Revenue Estimates and Forecasts 2015-2026
- 2.1.2 Global Glucose Monitoring Device Production Capacity Estimates and Forecasts 2015-2026
- 2.1.3 Global Glucose Monitoring Device Production Estimates and Forecasts 2015-2026
- 2.2 Global Glucose Monitoring Device, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.3 Analysis of Competitive Landscape
- 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
- 2.3.2 Global Glucose Monitoring Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.3.3 Global Glucose Monitoring Device Manufacturers Geographical Distribution
- 2.4 Key Trends for Glucose Monitoring Device Markets & Products
- 2.5 Primary Interviews with Key Glucose Monitoring Device Players (Opinion Leaders)
3 Market Size by Manufacturers
- 3.1 Global Top Glucose Monitoring Device Manufacturers by Production Capacity
- 3.1.1 Global Top Glucose Monitoring Device Manufacturers by Production Capacity (2015-2020)
- 3.1.2 Global Top Glucose Monitoring Device Manufacturers by Production (2015-2020)
- 3.1.3 Global Top Glucose Monitoring Device Manufacturers Market Share by Production
- 3.2 Global Top Glucose Monitoring Device Manufacturers by Revenue
- 3.2.1 Global Top Glucose Monitoring Device Manufacturers by Revenue (2015-2020)
- 3.2.2 Global Top Glucose Monitoring Device Manufacturers Market Share by Revenue (2015-2020)
- 3.2.3 Global Top 10 and Top 5 Companies by Glucose Monitoring Device Revenue in 2019
- 3.3 Global Glucose Monitoring Device Price by Manufacturers
- 3.4 Mergers & Acquisitions, Expansion Plans
4 Glucose Monitoring Device Production by Regions
- 4.1 Global Glucose Monitoring Device Historic Market Facts & Figures by Regions
- 4.1.1 Global Top Glucose Monitoring Device Regions by Production (2015-2020)
- 4.1.2 Global Top Glucose Monitoring Device Regions by Revenue (2015-2020)
- 4.2 North America
- 4.2.1 North America Glucose Monitoring Device Production (2015-2020)
- 4.2.2 North America Glucose Monitoring Device Revenue (2015-2020)
- 4.2.3 Key Players in North America
- 4.2.4 North America Glucose Monitoring Device Import & Export (2015-2020)
- 4.3 Europe
- 4.3.1 Europe Glucose Monitoring Device Production (2015-2020)
- 4.3.2 Europe Glucose Monitoring Device Revenue (2015-2020)
- 4.3.3 Key Players in Europe
- 4.3.4 Europe Glucose Monitoring Device Import & Export (2015-2020)
- 4.4 China
- 4.4.1 China Glucose Monitoring Device Production (2015-2020)
- 4.4.2 China Glucose Monitoring Device Revenue (2015-2020)
- 4.4.3 Key Players in China
- 4.4.4 China Glucose Monitoring Device Import & Export (2015-2020)
- 4.5 Japan
- 4.5.1 Japan Glucose Monitoring Device Production (2015-2020)
- 4.5.2 Japan Glucose Monitoring Device Revenue (2015-2020)
- 4.5.3 Key Players in Japan
- 4.5.4 Japan Glucose Monitoring Device Import & Export (2015-2020)
5 Glucose Monitoring Device Consumption by Region
- 5.1 Global Top Glucose Monitoring Device Regions by Consumption
- 5.1.1 Global Top Glucose Monitoring Device Regions by Consumption (2015-2020)
- 5.1.2 Global Top Glucose Monitoring Device Regions Market Share by Consumption (2015-2020)
- 5.2 North America
- 5.2.1 North America Glucose Monitoring Device Consumption by Application
- 5.2.2 North America Glucose Monitoring Device Consumption by Countries
- 5.2.3 U.S.
- 5.2.4 Canada
- 5.3 Europe
- 5.3.1 Europe Glucose Monitoring Device Consumption by Application
- 5.3.2 Europe Glucose Monitoring Device Consumption by Countries
- 5.3.3 Germany
- 5.3.4 France
- 5.3.5 U.K.
- 5.3.6 Italy
- 5.3.7 Russia
- 5.4 Asia Pacific
- 5.4.1 Asia Pacific Glucose Monitoring Device Consumption by Application
- 5.4.2 Asia Pacific Glucose Monitoring Device Consumption by Regions
- 5.4.3 China
- 5.4.4 Japan
- 5.4.5 South Korea
- 5.4.6 India
- 5.4.7 Australia
- 5.4.8 Taiwan
- 5.4.9 Indonesia
- 5.4.10 Thailand
- 5.4.11 Malaysia
- 5.4.12 Philippines
- 5.4.13 Vietnam
- 5.5 Central & South America
- 5.5.1 Central & South America Glucose Monitoring Device Consumption by Application
- 5.5.2 Central & South America Glucose Monitoring Device Consumption by Country
- 5.5.3 Mexico
- 5.5.3 Brazil
- 5.5.3 Argentina
- 5.6 Middle East and Africa
- 5.6.1 Middle East and Africa Glucose Monitoring Device Consumption by Application
- 5.6.2 Middle East and Africa Glucose Monitoring Device Consumption by Countries
- 5.6.3 Turkey
- 5.6.4 Saudi Arabia
- 5.6.5 U.A.E
6 Market Size by Type (2015-2026)
- 6.1 Global Glucose Monitoring Device Market Size by Type (2015-2020)
- 6.1.1 Global Glucose Monitoring Device Production by Type (2015-2020)
- 6.1.2 Global Glucose Monitoring Device Revenue by Type (2015-2020)
- 6.1.3 Glucose Monitoring Device Price by Type (2015-2020)
- 6.2 Global Glucose Monitoring Device Market Forecast by Type (2021-2026)
- 6.2.1 Global Glucose Monitoring Device Production Forecast by Type (2021-2026)
- 6.2.2 Global Glucose Monitoring Device Revenue Forecast by Type (2021-2026)
- 6.2.3 Global Glucose Monitoring Device Price Forecast by Type (2021-2026)
- 6.3 Global Glucose Monitoring Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 Market Size by Application (2015-2026)
- 7.2.1 Global Glucose Monitoring Device Consumption Historic Breakdown by Application (2015-2020)
- 7.2.2 Global Glucose Monitoring Device Consumption Forecast by Application (2021-2026)
8 Corporate Profiles
- 8.1 Roche
- 8.1.1 Roche Corporation Information
- 8.1.2 Roche Overview
- 8.1.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.1.4 Roche Product Description
- 8.1.5 Roche Related Developments
- 8.2 DexCom
- 8.2.1 DexCom Corporation Information
- 8.2.2 DexCom Overview
- 8.2.3 DexCom Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.2.4 DexCom Product Description
- 8.2.5 DexCom Related Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Corporation Information
- 8.3.2 Johnson & Johnson Overview
- 8.3.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.3.4 Johnson & Johnson Product Description
- 8.3.5 Johnson & Johnson Related Developments
- 8.4 AstraZeneca
- 8.4.1 AstraZeneca Corporation Information
- 8.4.2 AstraZeneca Overview
- 8.4.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.4.4 AstraZeneca Product Description
- 8.4.5 AstraZeneca Related Developments
- 8.5 Insulet
- 8.5.1 Insulet Corporation Information
- 8.5.2 Insulet Overview
- 8.5.3 Insulet Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.5.4 Insulet Product Description
- 8.5.5 Insulet Related Developments
- 8.6 Sanofi
- 8.6.1 Sanofi Corporation Information
- 8.6.2 Sanofi Overview
- 8.6.3 Sanofi Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.6.4 Sanofi Product Description
- 8.6.5 Sanofi Related Developments
- 8.7 Merck
- 8.7.1 Merck Corporation Information
- 8.7.2 Merck Overview
- 8.7.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.7.4 Merck Product Description
- 8.7.5 Merck Related Developments
- 8.8 GSK
- 8.8.1 GSK Corporation Information
- 8.8.2 GSK Overview
- 8.8.3 GSK Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.8.4 GSK Product Description
- 8.8.5 GSK Related Developments
- 8.9 Nova Biomedical
- 8.9.1 Nova Biomedical Corporation Information
- 8.9.2 Nova Biomedical Overview
- 8.9.3 Nova Biomedical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.9.4 Nova Biomedical Product Description
- 8.9.5 Nova Biomedical Related Developments
- 8.10 Becton Dickinson
- 8.10.1 Becton Dickinson Corporation Information
- 8.10.2 Becton Dickinson Overview
- 8.10.3 Becton Dickinson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.10.4 Becton Dickinson Product Description
- 8.10.5 Becton Dickinson Related Developments
- 8.11 Eli Lilly
- 8.11.1 Eli Lilly Corporation Information
- 8.11.2 Eli Lilly Overview
- 8.11.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.11.4 Eli Lilly Product Description
- 8.11.5 Eli Lilly Related Developments
- 8.12 Lupin
- 8.12.1 Lupin Corporation Information
- 8.12.2 Lupin Overview
- 8.12.3 Lupin Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.12.4 Lupin Product Description
- 8.12.5 Lupin Related Developments
- 8.13 Braun
- 8.13.1 Braun Corporation Information
- 8.13.2 Braun Overview
- 8.13.3 Braun Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.13.4 Braun Product Description
- 8.13.5 Braun Related Developments
- 8.14 Takeda Pharmaceutical
- 8.14.1 Takeda Pharmaceutical Corporation Information
- 8.14.2 Takeda Pharmaceutical Overview
- 8.14.3 Takeda Pharmaceutical Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.14.4 Takeda Pharmaceutical Product Description
- 8.14.5 Takeda Pharmaceutical Related Developments
- 8.15 Bayer HealthCare
- 8.15.1 Bayer HealthCare Corporation Information
- 8.15.2 Bayer HealthCare Overview
- 8.15.3 Bayer HealthCare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.15.4 Bayer HealthCare Product Description
- 8.15.5 Bayer HealthCare Related Developments
- 8.16 Abbott Diabetes Care
- 8.16.1 Abbott Diabetes Care Corporation Information
- 8.16.2 Abbott Diabetes Care Overview
- 8.16.3 Abbott Diabetes Care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.16.4 Abbott Diabetes Care Product Description
- 8.16.5 Abbott Diabetes Care Related Developments
- 8.17 Boehringer Ingelheim
- 8.17.1 Boehringer Ingelheim Corporation Information
- 8.17.2 Boehringer Ingelheim Overview
- 8.17.3 Boehringer Ingelheim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.17.4 Boehringer Ingelheim Product Description
- 8.17.5 Boehringer Ingelheim Related Developments
- 8.18 Novo Nordisk
- 8.18.1 Novo Nordisk Corporation Information
- 8.18.2 Novo Nordisk Overview
- 8.18.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.18.4 Novo Nordisk Product Description
- 8.18.5 Novo Nordisk Related Developments
- 8.19 GlySens
- 8.19.1 GlySens Corporation Information
- 8.19.2 GlySens Overview
- 8.19.3 GlySens Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.19.4 GlySens Product Description
- 8.19.5 GlySens Related Developments
- 8.20 Senseonics
- 8.20.1 Senseonics Corporation Information
- 8.20.2 Senseonics Overview
- 8.20.3 Senseonics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.20.4 Senseonics Product Description
- 8.20.5 Senseonics Related Developments
- 8.21 Novartis
- 8.21.1 Novartis Corporation Information
- 8.21.2 Novartis Overview
- 8.21.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.21.4 Novartis Product Description
- 8.21.5 Novartis Related Developments
- 8.22 Omron Healthcare
- 8.22.1 Omron Healthcare Corporation Information
- 8.22.2 Omron Healthcare Overview
- 8.22.3 Omron Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.22.4 Omron Healthcare Product Description
- 8.22.5 Omron Healthcare Related Developments
- 8.23 Philips Healthcare
- 8.23.1 Philips Healthcare Corporation Information
- 8.23.2 Philips Healthcare Overview
- 8.23.3 Philips Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.23.4 Philips Healthcare Product Description
- 8.23.5 Philips Healthcare Related Developments
- 8.24 GE Healthcare
- 8.24.1 GE Healthcare Corporation Information
- 8.24.2 GE Healthcare Overview
- 8.24.3 GE Healthcare Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.24.4 GE Healthcare Product Description
- 8.24.5 GE Healthcare Related Developments
- 8.25 Medtronic
- 8.25.1 Medtronic Corporation Information
- 8.25.2 Medtronic Overview
- 8.25.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.25.4 Medtronic Product Description
- 8.25.5 Medtronic Related Developments
- 8.26 ResMed
- 8.26.1 ResMed Corporation Information
- 8.26.2 ResMed Overview
- 8.26.3 ResMed Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
- 8.26.4 ResMed Product Description
- 8.26.5 ResMed Related Developments
9 Glucose Monitoring Device Production Forecast by Regions
- 9.1 Global Top Glucose Monitoring Device Regions Forecast by Revenue (2021-2026)
- 9.2 Global Top Glucose Monitoring Device Regions Forecast by Production (2021-2026)
- 9.3 Key Glucose Monitoring Device Production Regions Forecast
- 9.3.1 North America
- 9.3.2 Europe
- 9.3.3 China
- 9.3.4 Japan
10 Glucose Monitoring Device Consumption Forecast by Region
- 10.1 Global Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
- 10.2 North America Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
- 10.3 Europe Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
- 10.4 Asia Pacific Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
- 10.5 Latin America Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
- 10.6 Middle East and Africa Glucose Monitoring Device Consumption Forecast by Region (2021-2026)
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Glucose Monitoring Device Sales Channels
- 11.2.2 Glucose Monitoring Device Distributors
- 11.3 Glucose Monitoring Device Customers
12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
- 12.1 Glucose Monitoring Device Industry
- 12.2 Market Trends
- 12.3 Market Opportunities and Drivers
- 12.4 Market Challenges
- 12.5 Glucose Monitoring Device Market Risks/Restraints
- 12.6 Porter's Five Forces Analysis
13 Key Finding in The Global Glucose Monitoring Device Study
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.2 Data Source
- 14.2 Author Details
Description
Glucose Monitoring Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glucose Monitoring Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glucose Monitoring Device market is segmented into
Diabetes monitoring devices
Insulin delivery devices
Segment by Application, the Glucose Monitoring Device market is segmented into
Hospitals
Personal use
Regional and Country-level Analysis
The Glucose Monitoring Device market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glucose Monitoring Device market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Glucose Monitoring Device Market Share Analysis
Glucose Monitoring Device market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Glucose Monitoring Device by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Glucose Monitoring Device business, the date to enter into the Glucose Monitoring Device market, Glucose Monitoring Device product introduction, recent developments, etc.
The major vendors covered:
Roche
DexCom
Johnson & Johnson
AstraZeneca
Insulet
Sanofi
Merck
GSK
Nova Biomedical
Becton Dickinson
Eli Lilly
Lupin
Braun
Takeda Pharmaceutical
Bayer HealthCare
Abbott Diabetes Care
Boehringer Ingelheim
Novo Nordisk
GlySens
Senseonics
Novartis
Omron Healthcare
Philips Healthcare
GE Healthcare
Medtronic
ResMed